James Christensen has a wealth of experience in the pharmaceutical industry, currently serving as the CSO and EVP Research at Mirati Therapeutics, a Bristol Myers Squibb Company. Prior to their current role, James held various senior positions at companies such as Pfizer and Pharmacia Corporation. James also has a background in oncology precision medicine and has a strong leadership background, having served as a Group Leader at SUGEN and a Team Leader at Pharmacia Corporation.
Current role
EVP, Chief Scientific Officer at Seres Therapeutics
EVP, Chief Scientific Officer at vTv Therapeutics
EVP, Chief Scientific Officer at Ionis Pharmaceuticals
EVP, Chief Scientific Officer at Intellia Therapeutics
EVP, Chief Scientific Officer at ILIAS Biologics Inc.